Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(-)-Indolactam V is an indole alkaloid compound that activates protein kinase C (PKC) and acts at the phorbol ester binding site. It is known for its ability to direct the differentiation of human and mouse embryonic stem cells (ESCs) into pancreatic cells, making it a promising candidate for diabetes therapy. Additionally, it increases the levels of regulator of G protein signaling 2 (RGS2) protein, which plays a role in regulating GPCR signaling.

90365-57-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 90365-57-4 Structure
  • Basic information

    1. Product Name: (-)-INDOLACTAM V
    2. Synonyms: (2s-(2r*,5r*))-ethyl)-1-methyl-2-(1-methylethyl);3h-pyrrolo(4,3,2-gh)-1,4-benzodiazonin-3-one,1,2,4,5,6,8-hexahydro-5-(hydroxym;(-)-INDOLACTAM V;(2S,5S)-1,2,4,5,6,8-Hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one;(-)-Ilv;3H-Pyrrolo(4,3,2-gh)-1,4-benzodiazonin-3-one, 1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-, (2S-(2R*,5R*))-;3H-Pyrrolo(4,3,2-gh)-1,4-benzodiazonin-3-one, 1,2,4,5,6,8-hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-, (2S,5S)-;Brn 4711877
    3. CAS NO:90365-57-4
    4. Molecular Formula: C17H23N3O2
    5. Molecular Weight: 301.38
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 90365-57-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 584 °C at 760 mmHg
    3. Flash Point: 307 °C
    4. Appearance: White to off-white solid.
    5. Density: 1.166 g/cm3
    6. Vapor Pressure: 1.75E-14mmHg at 25°C
    7. Refractive Index: 1.589
    8. Storage Temp.: −20°C
    9. Solubility: DMSO: >10mg/mL, clear
    10. PKA: 14.39±0.10(Predicted)
    11. Stability: Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 2 months.
    12. CAS DataBase Reference: (-)-INDOLACTAM V(CAS DataBase Reference)
    13. NIST Chemistry Reference: (-)-INDOLACTAM V(90365-57-4)
    14. EPA Substance Registry System: (-)-INDOLACTAM V(90365-57-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS: UY8547000
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 90365-57-4(Hazardous Substances Data)

90365-57-4 Usage

Uses

Used in Pharmaceutical Industry:
(-)-Indolactam V is used as a PKC activator for its potential role in activating protein kinase C, which is involved in various cellular processes.
Used in Diabetes Therapy:
(-)-Indolactam V is used as a differentiation agent for directing the differentiation of human embryonic stem cells into pancreatic lineage cells, which may contribute to the development of effective diabetes treatments.
Used in Stem Cell Research:
(-)-Indolactam V is used as a tool to study the differentiation of human induced pluripotent stem (iPS) cells into glucose-responsive insulin-secreting progeny, furthering our understanding of stem cell biology and its potential applications in regenerative medicine.
Used in GPCR Signaling Regulation:
(-)-Indolactam V is used as a regulator of G protein-coupled receptor (GPCR) signaling due to its ability to increase RGS2 protein levels, which play a role in modulating GPCR signaling pathways.

Biological Activity

Protein kinase C activator. Exhibits tumor promoting activity. Directs differentiation of human embryonic stem cells (ESCs) into pancreatic progenitors.

Biochem/physiol Actions

(-)-Indolactam V is a PKC activator shown to effect differentiation in embryonic stem cells leading to development of pancreatic precursors. It is active in the mouse model.

References

1) Fujiki?et al.?(1984),?Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin; Gan., 75?866 2) Heikkila and Ackerman (1989),?(-)-Indolactam V activates protein kinase C and induces changes in muscarinic receptor functions in SH-SY5Y human neuroblastoma cells; Biochem. Biophys. Res. Commun,?162?1207 3) Chen?et al.?(2009),?A small molecule that directs differentiation of human ESCs into the pancreatic lineage; Nat. Chem. Biol.,?5?258 4) Thalava?et al. (2011),?Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secretin progeny; Gene Ther.,?18?283 5) Raveh (2014),?Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts; Mol. Pharmacol.,?86?406

Check Digit Verification of cas no

The CAS Registry Mumber 90365-57-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,3,6 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 90365-57:
(7*9)+(6*0)+(5*3)+(4*6)+(3*5)+(2*5)+(1*7)=134
134 % 10 = 4
So 90365-57-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H23N3O2/c1-10(2)16-17(22)19-12(9-21)7-11-8-18-13-5-4-6-14(15(11)13)20(16)3/h4-6,8,10,12,16,18,21H,7,9H2,1-3H3,(H,19,22)/t12-,16-/m0/s1

90365-57-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (I0661)  (−)-Indolactam V  ≥96% (HPLC)

  • 90365-57-4

  • I0661-1MG

  • 2,932.02CNY

  • Detail

90365-57-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-Indolactam V,(2S,5S)-1,2,4,5,6,8-Hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one

1.2 Other means of identification

Product number -
Other names indolactam V

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:90365-57-4 SDS

90365-57-4Relevant articles and documents

Exploiting a C–N Bond Forming Cytochrome P450 Monooxygenase for C–S Bond Formation

Abe, Ikuro,Fujita, Makoto,Hoshino, Shotaro,Kikuchi, Takashi,Mitsuhashi, Takaaki,Mori, Takahiro,Morita, Iori,Nagae, Kei,Nasu, Norihiro,Ohwada, Tomohiko,Taniguchi, Yoshimasa

supporting information, p. 3988 - 3993 (2020/02/05)

C–S bond formation reactions are widely distributed in the biosynthesis of biologically active molecules, and thus have received much attention over the past decades. Herein, we report intramolecular C–S bond formation by a P450 monooxygenase, TleB, which normally catalyzes a C?N bond formation in teleocidin biosynthesis. Based on the proposed reaction mechanism of TleB, a thiol-substituted substrate analogue was synthesized and tested in the enzyme reaction, which afforded the unprecedented sulfur-containing thio-indolactam V, in addition to an unusual indole-fused 6/5/8-tricyclic product whose structure was determined by the crystalline sponge method. Interestingly, conformational analysis revealed that the SOFA conformation is stable in thio-indolactam V, in sharp contrast to the major TWIST form in indolactam V, resulting in differences in their biological activities.

11-Step Total Synthesis of Teleocidins B-1-B-4

Nakamura, Hugh,Yasui, Kosuke,Kanda, Yuzuru,Baran, Phil S.

, p. 1494 - 1497 (2019/01/26)

A unified and modular approach to the teleocidin B family of natural products is presented that proceeds in 11 steps and features an array of interesting strategies and methods. Indolactam V, the known biosynthetic precursor to this family, was accessed through electrochemical amination, Cu-mediated aziridine opening, and a remarkable base-induced macrolactamization. Guided by a desire to minimize concession steps, the tactical combination of C-H borylation and a Sigman-Heck transform enabled the convergent, stereocontrolled synthesis of the teleocidins.

The Synthesis and Biological Evaluation of Indolactam Alkaloids

Billingsley, Kelvin L.,Eom, Ryan,Haynes-Smith, Jeremy,Mendoza, Manuel,Salas, Celeste

, p. 4443 - 4451 (2019/11/21)

In this work, we execute a general synthetic strategy to access novel indolactam alkaloids, which are agonists of protein kinase C. This protocol allowed for the most efficient reported syntheses of indolactam V (ILV) stereoisomers, while also affording t

Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells

Stein, Jan,Stahn, Sonja,Neud?rfl, J?rg-M.,Sperlich, Julia,Schmalz, Hans-Günther,Teusch, Nicole

, p. 147 - 154 (2018/02/06)

Human proteinase-activated receptor 2 (PAR2), a transmembrane G-protein-coupled receptor (GPCR), is an attractive target for a novel anticancer therapy, as it plays a critical role in cell migration and invasion. Selective PAR2 inhibitors therefore have potential as anti-metastatic drugs. Knowing that the natural product teleocidin A2 is able to inhibit PAR2 in tumor cells, the goal of the present study was to elaborate structure–activity relationships and to identify potent PAR2 inhibitors with lower activity against the adverse target, protein kinase C (PKC). For this purpose, an efficient gram-scale total synthesis of indolactam V (i.e., the parent structure of all teleocidins) was developed, and a library of derivatives was prepared. Some compounds were indeed found to exhibit high potency as PAR2 inhibitors at low nanomolar concentrations with improved selectivity (relative to teleocidin A2). The pseudopeptidic fragment bridging the C3 and C4 positions of the indole core proved to be essential for target binding, whereas activity and target selectivity depends on the substituents at N1 or C7. This study revealed novel derivatives that show high efficacy in PAR2 antagonism combined with increased selectivity.

Modular Total Synthesis of Protein Kinase C Activator (-)-Indolactam v

Haynes-Smith, Jeremy,Diaz, Italia,Billingsley, Kelvin L.

, p. 2008 - 2011 (2016/06/01)

A concise, eight-step total synthesis of (-)-indolactam V, a nanomolar agonist of protein kinase C, is reported. The synthesis relies upon an efficient copper-catalyzed amino acid arylation to establish the indole C4-nitrogen bond. This cross-coupling met

A concise total synthesis of (-)-indolactam v

Noji, Toshiharu,Okano, Kentaro,Tokuyama, Hidetoshi

supporting information, p. 3833 - 3837 (2015/06/02)

One-pot synthesis of tryptophanol derivative from N-Boc-aziridine and indole has been developed. The ring opening reaction of the aziridine takes place smoothly at -30°C in a regioselective manner and tolerates a wide range of functional groups including

Total syntheses of indolactam alkaloids (-)-indolactam V, (-)-pendolmycin, (-)-lyngbyatoxin A, and (-)-teleocidin A-2

Fine Nathel, Noah F.,Shah, Tejas K.,Bronner, Sarah M.,Garg, Neil K.

, p. 2184 - 2190 (2014/05/20)

We report the total syntheses of (-)-indolactam V and the C7-substituted indolactam alkaloids (-)-pendolmycin, (-)-lyngbyatoxin A, and (-)-teleocidin A-2. The strategy for preparing indolactam V relies on a distortion-controlled indolyne functionalization reaction to establish the C4-N linkage, in addition to an intramolecular conjugate addition to build the conformationally-flexible nine-membered ring. The total synthesis of indolactam V then sets the stage for the divergent synthesis of the other targeted alkaloids. Specifically, late-stage sp2-sp3 cross-couplings on an indolactam V derivative are used to introduce the key C7 substituents and the necessary quaternary carbons. These challenging couplings, in addition to other delicate manipulations, all proceed in the presence of a basic tertiary amine, an unprotected secondary amide, and an unprotected indole. Thus, our approach not only enables the enantiospecific total syntheses of four indolactam alkaloids, but also serves as a platform for probing complexity-generating and chemoselective transformations in the context of alkaloid total synthesis. This journal is the Partner Organisations 2014.

Synthesis of (-)-epi-indolactam v by an intramolecular Buchwald-Hartwig C-N coupling cyclization reaction

Mari, Michele,Bartoccini, Francesca,Piersanti, Giovanni

, p. 7727 - 7734 (2013/09/02)

The synthetic efforts toward the concise synthesis of (-)-indolactam V from simple and commercially available starting materials using palladium- and copper-catalyzed intramolecular N-arylation strategy for the elaboration of the requisite nine-membered lactam ring as the key step are described. The incorporation of a turn-inducing structural element along the linear precursor was fundamental to achieve the heterocyclization step as well as obtain the correct regio- and chemoselectivity. The stereoselective nature in the C-N coupling cyclization reaction is interpreted in terms of minimization of allylic strain at the transition state for the palladium-amido complex formation. Meanwhile, the synthesis of the (-)-epi-indolactam V and its enantiomer have been accomplished.

Total synthesis of (-)-indolactam v

Xu, Zhengren,Zhang, Fengying,Zhang, Lihe,Jia, Yanxing

, p. 2512 - 2517 (2011/05/06)

The total synthesis of protein kinase C activator (-)-indolactam V (IL-V) has been successfully completed with two separate approaches: From known 4-nitrotryptophan derivative 3 in 8 steps (49% overall yield) and from l-glutamic acid in 12 steps (18% overall yield), where 4-nitrotryptophanol derivative 4 served as a key intermediate. Derivatives 3 and 4, both incorporating indole 4-substitution and the C-9 stereocenter in IL-V, were synthesized via the Pd-catalyzed indole synthesis from 3-nitro-2-iodoaniline 5 with aldehydes 6 and 7, respectively. Aldehyde 7 was, meanwhile, synthesized from l-glutamic acid in 5 steps (68% yield). Lactamization of the 9-membered ring was achieved using HATU in THF in good yield.

Enzymatic production of (-)-indolactam V by LtxB, a cytochrome P450 monooxygenase

Huynh, Minh U.,Elston, Matthew C.,Hernandez, Nick M.,Ball, David B.,Kajiyama, Shin-Ichiro,Irie, Kazuhiro,Gerwick, William H.,Edwards, Daniel J.

experimental part, p. 71 - 74 (2010/04/28)

The P450 cytochrome monooxygenase gene, ltxB, was cloned and overexpressed in Escherichia coli as a 6xHis-tagged protein. The resulting recombinant LtxB was purified by Ni-NTA affinity chromatography and characterized biochemically. Purified LtxB demonstrated typical cytochrome P450 spectroscopic properties including substrate-induced transition from a low-spin (λmax = 414 nm) to high-spin state (λmax = 386 nm) upon incubation with N-methyl-L-valyl-L-tryptophanol. The catalytic activity of LtxB was verified by demonstrating the oxidation/cyclization of N-methyl-L-valyl-L- tryptophanol to (-)-indolactam V. LtxB shows a relaxed specificity for analogue substrates in which the valyl group is substituted for other aliphatic groups. The relaxed substrate specificity of LtxB, along with the relaxed specificity of the prenyltransferase, LtxC, allowed for the enzymatic production of a series of (-)-indolactam V and lyngbyatoxin analogues.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 90365-57-4